All Posts By

Dr Anna D. Barker

GBM AGILE – A Story of Convergence, Commitment, Collaboration and Compassion

By Brain Tumour Magazine 2016/17

This article was written by Dr Anna D. Baker, Executive Committee Chair, GBM AGILE Trial, and was first published in the 2016/17 edition of Brain Tumour, the IBTA's annual magazine that is distributed globally and free of charge in 113 countries and at international neuro-oncology and cancer conferences around the world. Read the full issue online and find out more here.

Glioblastoma is Unacceptable

GBM AGILE logoTens of thousands of people are diagnosed with glioblastoma multiforme (GBM) on a global basis each year. With a median survival of 14 months and only 5% of patients living five years or longer, GBM is a grim diagnosis. Despite hundreds of GBM clinical trials, testing hundreds of agents, there have only been four approved GBM treatments, and the dismal prognosis for GBM patients has not changed in decades. Read More

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.